| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 138.309 | 153.240 | 163.736 | 172.360 | 198.926 | 199.201 | 340.000 | 278.432 | 296.919 | 361.909 |
| Total Income - EUR | 138.368 | 153.315 | 163.792 | 172.387 | 198.999 | 199.321 | 340.175 | 279.909 | 299.017 | 371.214 |
| Total Expenses - EUR | 117.674 | 156.765 | 193.418 | 125.617 | 137.071 | 125.062 | 183.707 | 181.617 | 195.333 | 279.030 |
| Gross Profit/Loss - EUR | 20.694 | -3.450 | -29.627 | 46.770 | 61.928 | 74.259 | 156.468 | 98.292 | 103.683 | 92.184 |
| Net Profit/Loss - EUR | 16.291 | -4.721 | -31.378 | 45.046 | 59.938 | 72.266 | 153.067 | 95.492 | 100.695 | 81.039 |
| Employees | 0 | 5 | 6 | 7 | 7 | 9 | 10 | 9 | 7 | 8 |
Check the financial reports for the company - Vitamed M&L S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 153 | 1.041 | 839 | 721 | 1.082 | 2.892 | 2.005 | 26.044 | 23.205 | 16.582 |
| Current Assets | 46.779 | 35.287 | 50.257 | 65.976 | 116.132 | 203.134 | 320.180 | 275.410 | 282.841 | 125.043 |
| Inventories | 1.336 | 3.435 | 1.808 | 595 | 583 | 938 | 917 | 920 | 0 | 0 |
| Receivables | 10.488 | 12.873 | 25.145 | 14.237 | 21.708 | 23.751 | 22.196 | 47.852 | 43.130 | 6.980 |
| Cash | 34.955 | 18.979 | 23.304 | 51.144 | 93.841 | 178.445 | 297.067 | 226.638 | 239.711 | 118.063 |
| Shareholders Funds | 4.480 | -287 | -31.660 | 13.967 | 73.635 | 144.505 | 294.367 | 246.239 | 223.819 | 81.343 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 42.453 | 36.615 | 82.756 | 52.730 | 43.580 | 61.521 | 30.648 | 57.610 | 82.051 | 59.110 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.863 | 1.592 | 1.173 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Vitamed M&L S.r.l.